Sherko Kümmel
Sherko Kümmel
Professor für Medizin, Kliniken Essen-Mitte, Wissenschaftlicher Mitarbeiter Charité Berlin
Verified email at kem-med.com - Homepage
Title
Cited by
Cited by
Year
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
G Von Minckwitz, A Schneeweiss, S Loibl, C Salat, C Denkert, M Rezai, ...
The lancet oncology 15 (7), 747-756, 2014
6322014
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
TJ Vogl, S Kümmel, R Hammerstingl, M Schellenbeck, G Schumacher, ...
Radiology 200 (1), 59-67, 1996
4781996
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
C Denkert, G von Minckwitz, S Darb-Esfahani, B Lederer, BI Heppner, ...
The lancet oncology 19 (1), 40-50, 2018
3752018
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association …
E De Azambuja, AP Holmes, M Piccart-Gebhart, E Holmes, S Di Cosimo, ...
The lancet oncology 15 (10), 1137-1146, 2014
3542014
Real‐time elastography—an advanced method of ultrasound: first results in 108 patients with breast lesions
A Thomas, T Fischer, H Frey, R Ohlinger, S Grunwald, JU Blohmer, ...
Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2006
3542006
Neoadjuvant vinorelbine–capecitabine versus docetaxel–doxorubicin–cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial
G von Minckwitz, S Kümmel, P Vogel, C Hanusch, H Eidtmann, J Hilfrich, ...
Journal of the National Cancer Institute 100 (8), 542-551, 2008
2962008
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study
G von Minckwitz, S Kümmel, P Vogel, C Hanusch, H Eidtmann, J Hilfrich, ...
Journal of the National Cancer Institute 100 (8), 552-562, 2008
2782008
Response-guided neoadjuvant chemotherapy for breast cancer
G von Minckwitz, JU Blohmer, SD Costa, C Denkert, H Eidtmann, ...
Journal of Clinical Oncology 31 (29), 3623-3630, 2013
2612013
Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
G von Minckwitz, M Untch, E Nüesch, S Loibl, M Kaufmann, S Kümmel, ...
Breast cancer research and treatment 125 (1), 145-156, 2011
2552011
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, SA Hurvitz, ...
The lancet oncology 19 (7), 904-915, 2018
2472018
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
M Untch, C Jackisch, A Schneeweiss, B Conrad, B Aktas, C Denkert, ...
The Lancet Oncology 17 (3), 345-356, 2016
2052016
Real-time sonoelastography of the cervix: tissue elasticity of the normal and abnormal cervix
A Thomas, S Kümmel, O Gemeinhardt, T Fischer
Academic radiology 14 (2), 193-200, 2007
2012007
Real-time sonoelastography performed in addition to B-mode ultrasound and mammography: improved differentiation of breast lesions?
A Thomas, S Kümmel, F Fritzsche, M Warm, B Ebert, B Hamm, T Fischer
Academic radiology 13 (12), 1496-1504, 2006
1892006
West German Study Group Phase III PlanB Trial: first prospective outcome data for the 21-gene recurrence score assay and concordance of prognostic markers by central and local …
O Gluz, UA Nitz, M Christgen, RE Kates, S Shak, M Clemens, S Kraemer, ...
J Clin Oncol 34 (20), 2341-2349, 2016
1832016
Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: secondary analysis of the GeparSixto randomized clinical trial
E Hahnen, B Lederer, J Hauke, S Loibl, S Kröber, A Schneeweiss, ...
JAMA oncology 3 (10), 1378-1385, 2017
1792017
Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging
TA Heusner, S Kuemmel, A Koeninger, ME Hamami, S Hahn, A Quinsten, ...
European journal of nuclear medicine and molecular imaging 37 (6), 1077-1086, 2010
1582010
Pegfilgrastim±ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
G Von Minckwitz, S Kümmel, A Du Bois, W Eiermann, H Eidtmann, ...
Annals of Oncology 19 (2), 292-298, 2008
1582008
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted …
W Eiermann, M Rezai, S Kümmel, T Kühn, M Warm, K Friedrichs, ...
Annals of oncology 24 (3), 618-624, 2013
1432013
Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients
TA Heusner, S Kuemmel, S Hahn, A Koeninger, F Otterbach, ME Hamami, ...
European journal of nuclear medicine and molecular imaging 36 (10), 1543-1550, 2009
1222009
Breast cancer staging in a single session: whole-body PET/CT mammography
TA Heusner, S Kuemmel, L Umutlu, A Koeninger, LS Freudenberg, ...
Journal of Nuclear Medicine 49 (8), 1215-1222, 2008
1192008
The system can't perform the operation now. Try again later.
Articles 1–20